You have 9 free searches left this month | for more free features.

mMR

Showing 1 - 25 of 591

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial in Jette (68GaNOTA-Anti-MMR-VHH2)

Recruiting
  • Non-small Cell Lung Cancer
  • Jette, Brussel, Belgium
    Universitair Ziekenhuis Brussel
Jun 27, 2023

Tumor Vaccine Benefit for Gliomas

Recruiting
  • Glioma
  • DC vaccine
  • Shanghai, China
    Huashan Hospital,Fudan University
Sep 12, 2023

Developing a MRI-based Deep Learning Model to Predict MMR Status

Not yet recruiting
  • Endometrial Cancer
  • randomly divided
  • (no location specified)
Mar 13, 2023

IsThird Dose of MMRV Vaccine Beneficial for Adult Population in

Not yet recruiting
  • Vaccination Failure
  • Vaccine Response Impaired
  • Serology for antibody levels - Baseline
  • +3 more
  • (no location specified)
Jun 26, 2023

Squamous Cell Carcinoma of Head and Neck, Cancer, Carotid Stenosis Trial in Brussels (68GaNOTA-Anti-MMR-VHH2)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +7 more
  • Brussels, Brussel, Belgium
    Uz Brussel
Sep 2, 2022

Colon Cancer Trial (Pembrolizumab)

Not yet recruiting
  • Colon Cancer
  • (no location specified)
Dec 14, 2022

COVID-19 Trial in Goiânia (Influenza, MMR vaccines, Placebo)

Recruiting
  • COVID-19
  • Influenza
  • +2 more
  • Goiânia, Goiás, Brazil
    Faculdade da Polícia Militar
May 27, 2022

Tumor Budding in Colorectal Cancer Under Different MMR Status

Completed
  • Tumor Budding
  • Rectal Cancer
  • total mesorectal exicision
  • Guangzhou, Guangdong, China
    Department of colorectal surgery, the Sixth Affiliated Hospital,
Nov 8, 2022

Toripalimab, Radiation Trial in Hangzhou (Toripalimab, CRT, SCRT)

Recruiting
  • Toripalimab
  • Radiation
  • Hangzhou, Zhejiang, China
    Zhengjiang Cancer Hospital
Dec 29, 2022

Cancer, Coronary Artery Disease Trial in Los Angeles (PET-MR imaging on Biograph mMR scanner, MR-only imaging on Biograph mMR

Recruiting
  • Cancer
  • Coronary Artery Disease
  • PET-MR imaging on Biograph mMR scanner
  • +2 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 7, 2022

Mumps, Measles, Rubella Trial in Zürich (MMR booster vaccination (as M-M-R-VaxPro))

Not yet recruiting
  • Mumps
  • +2 more
  • MMR booster vaccination (as M-M-R-VaxPro)
  • Zürich, Switzerland
    Epidemiology, Biostatistics and Prevention Institute University
Jun 8, 2023

Chronic Disease Trial in Montpellier, Nîmes, Toulouse (Mutlidisciplinary medication Review (MMR), Mutlidisciplinary medication

Recruiting
  • Chronic Disease
  • Mutlidisciplinary medication Review (MMR)
  • Mutlidisciplinary medication Review (MMR) with community pharmacist follow-up
  • Montpellier, France
  • +2 more
Jan 6, 2023

Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

Recruiting
  • Colorectal Neoplasms
  • Microsatellite Instability
  • temozolomide (induction),
  • pembrolizumab (treatment)
  • Milano, Italy
  • +3 more
Sep 28, 2022

Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic Trial in Baltimore (Neoantigen Vaccine with Poly-ICLC adjuvant,

Not yet recruiting
  • Pancreatic Cancer Metastatic
  • Colorectal Cancer Metastatic
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 5, 2022

Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Measles Trial in Shaoxing, Wuyi

Active, not recruiting
  • Human Papilloma Virus Infection Type 16
  • +4 more
  • HPV+MMR(0d),HPV(6m)
  • +2 more
  • Shaoxing, Zhejiang, China
  • +1 more
Mar 14, 2022

Respiratory Tract Infections, Infections, Allergy Trial in Geneva (Measles-Mumps-Rubella vaccine (MMR))

Not yet recruiting
  • Respiratory Tract Infections
  • +3 more
  • Measles-Mumps-Rubella vaccine (MMR)
  • Geneva, Switzerland
    University Hospitals of Geneva
Feb 24, 2023

Colorectal Cancer, Liver Metastases, MSS Trial (Sinti+Rego+Cele)

Not yet recruiting
  • Colorectal Cancer
  • +2 more
  • (no location specified)
Jul 3, 2023

Colorectal Cancer Trial in Essen (Atezolizumab)

Recruiting
  • Colorectal Cancer
  • Essen, Germany
    Westdeutsches Tumorzentrum
Feb 14, 2022

SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

Not yet recruiting
  • SARS-CoV-2 Infection
  • +4 more
  • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023

es to Capture the Real Life of Children With Rare Eye Diseases

Not yet recruiting
  • Eye Diseases
  • +3 more
  • Mixed Methods Research (MMR) using quantitative (QUAN) and qualitative (QUAL) tools
  • Strasbourg, France
    Centre de Référence pour les Affections Rares en Génétique Ophta
Oct 3, 2023

Childhood Cancer, Multiple Diseases Trial in New York (Immunization Schedule patients <7 years., Immunization Schedule patients

Active, not recruiting
  • Childhood Cancer
  • Multiple Diseases
  • Immunization Schedule patients <7 years.
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center 1275 York Avenue
Aug 9, 2022

Biomarkers of Trained Immunity Following MMR Vaccination

Completed
  • Covid19
  • Heterologous stimuli
  • Neutralization assay
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 24, 2021

Preventable Disease, Vaccine, Health Care Utilization Trial in Cincinnati (1 automated message, 2 automated messages, No

Completed
  • Preventable Disease, Vaccine
  • Health Care Utilization
  • 1 automated message
  • +3 more
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 12, 2021

Dengue, Dengue Hemorrhagic Fever, Yellow Fever Trial in Cali, Lima (Live, attenuated dengue serotype 1, 2, 3, and 4 virus,

Completed
  • Dengue
  • +2 more
  • Live, attenuated dengue serotype 1, 2, 3, and 4 virus
  • +8 more
  • Cali, Colombia
  • +1 more
Mar 15, 2022

Ontogeny of Measles Immunity in Infants

Completed
  • Measles
  • Attenuvax (Measles Virus Live Vaccine, 0.5ml subcutaneous)
  • MMR-II (Measles-Mumps-Rubella Virus Live Vaccine, 0.5ml subcutaneous)
  • Palo Alto, California
  • +1 more
Jun 6, 2022